Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles.

@article{Mandell2010NovelSC,
  title={Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles.},
  author={Robert B. Mandell and Ramesh Koukuntla and Laura J K Mogler and Andrea K Carzoli and Michael R. Holbrook and Brian K Martin and Nicholas N. Vahanian and Charles J. Link and Ramon Flick},
  journal={Journal of virological methods},
  year={2010},
  volume={169 2},
  pages={259-68}
}
Rift Valley fever virus (RVFV) is an arthropod-borne pathogen that often results in severe morbidity and mortality in both humans and livestock. As its geographic range continues to expand, it presents a real threat to naïve populations around the world by accidental introduction (e.g., the result of increased travel) or intentional release (e.g., a bioterror event). While there is a clear need for a safe and efficacious vaccine against this emerging and re-emerging pathogen, no FDA-approved… CONTINUE READING